Companies / Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp.

Nasdaq: PHIOCIK 1533040KING OF PRUSSIA, PA
Insider flow · last 90 daysNet buys $9.9K

Financials · FY2020

Revenue$0
Net income$-8.70M
Total debt$0
Cash$13.00M
Diluted EPS$-9.08
Shares outstanding11.6M

Ownership

11.6M shares outstanding · as of Aug 4, 2026
5.7%Insiders
Ownership
Insiders5.74%666,682
Institutions3.93%456,361
Public float90.33%10,494,207

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Bitterman Robert JCEOChairman, Pres. & CEO · Director
3.63%421,421
Carson Lisa CabottChief Financial Officer
0.81%94,000
Bradford Patricia aDirector
0.39%45,651
Deming David HDirector
0.33%37,800
Lockshin CurtisDirector
0.30%35,155
Freeman Jonathan EDirector
0.28%32,655

Institutional holders 20

View all →
HolderValue% of shares
Geode Capital Management, LLC$179.6K1.27%
Vanguard Group Inc$92.0K0.75%
Cetera Investment Advisers$44.6K0.37%
Two Sigma Investments, LP$39.6K0.28%
Northern Trust Corp$24.9K0.20%
DRW Securities, LLC$23.8K0.19%
Susquehanna International Group, LLP$21.1K0.17%
StoneX Group Inc.$12.4K0.10%
Robertson Stephens Wealth Management, LLC$11.3K0.09%
Captrust Financial Advisors$10.5K0.09%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 26, 2026Bitterman Robert J
CEO
BuyCommon Stock, $.0001 par value$9.9K+10K
+2.43%
421,421
3.63% of shares
low
Dec 31, 2025Bitterman Robert J
CEO
BuyCommon Stock, $.0001 par value$5.2K+5K
+1.75%
291,421
2.51% of shares
low
Feb 5, 2026Freeman Jonathan E
Director
GrantCommon Stock, $.0001 par value$0+17K
+103.39%
32,655
0.28% of shares
low
Feb 5, 2026Deming David H
Director
GrantCommon Stock, $.0001 par value$0+24K
+170.00%
37,800
0.33% of shares
low
Feb 5, 2026Lockshin Curtis
Director
GrantCommon Stock, $.0001 par value$0+17K
+89.46%
35,155
0.30% of shares
low
Feb 5, 2026Carson Lisa Cabott
Executive
GrantCommon Stock, $.0001 par value$0+47K
+100.00%
94,000
0.81% of shares
low
Feb 5, 2026Bradford Patricia a
Director
GrantCommon Stock, $.0001 par value$0+19K
+68.14%
45,651
0.39% of shares
low
Feb 5, 2026Bitterman Robert J
CEO
GrantCommon Stock, $.0001 par value$0+120K
+41.18%
411,421
3.54% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Mitchell P. KopinPassive13G/A———
CVI Investments, Inc.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PHIOCommon StockEquity71880W501BBG0024FKD97